Patent Assignment
Reel/Frame 053411/0496
Release of Security Interest
Recorded: 2020-08-05
Pages: 17
Assignor
U.S. BANK NATIONAL ASSOCIATION
Executed: 2020-08-05
Assignees
ZYLA LIFE SCIENCES, F/K/A EGALET CORPORATION
600 LEE ROAD, SUITE 100, WAYNE, PENNSYLVANIA, 19087
ZYLA LIFE SCIENCES US INC., F/K/A EGALET US, INC.
600 LEE ROAD, SUITE 100, WAYNE, PENNSYLVANIA, 19087
EGALET LIMITED
C/O DECHERT LLP, 160 QUEEN VICTORIA STREET, LONDON, EC4V 4QQ, UNITED KINGDOM
Covered Properties
(36)
Controlled Release Composition
Patent:
6,787,156 →
Application:
08/693,254 →
Morphine controlled release system
Matrix Compositions for Controlled Delivery of Drug Substances
Controlled Release Composition
Swellable Dosage Form Comprising Gellan Gum
Solid Pharmaceutical Composition with a First Fraction of a Dispersion Medium and a Second Fraction of a Matrix, the Latter Being at Least Partially First Exposed to Gastrointestinal Fluids
Application:
11/915,655 →
Publication:
US 2009/0274759
Polymer release system
Controlled release carvedilol compositions
Morphine Polymer Release System
Device for Intranasal Administration
Pharmaceutical Compositions and Methods for Mitigating Risk of Alcohol Induced Dose Dumping or Drug Abuse
Application:
12/523,045 →
Publication:
US 2010/0291205
Controlled Release Pharmaceutical Compositions for Prolonged Effect
Immediate Release Composition Resistant to Abuse by Intake of Alcohol
Pharmaceutical Compositions Resistant to Abuse
Device for Intranasal Administration
Formulations and Methods for the Controlled Release of Active Drug Substances
Swellable Dosage Form Comprising Gellan Gum
Stabilized Ketorolac Compositions
Application:
13/786,293 →
Publication:
US 2013/0274650
Device for Intranasal Administration of Ketorolac
Application:
13/791,780 →
Publication:
US 2013/0186391
Formulations and Methods for the Controlled Release of Active Drug Substances
Formulations and Methods for the Controlled Release of Active Drug Substances
Application:
13/928,190 →
Publication:
US 2013/0287850
Abuse Deterrent Pharmaceutical Compositions for Controlled Release
Morphine Polymer Release System
Polymer Release System
Pharmaceutical Compositions Resistant to Abuse
Abuse-Deterrent Pharmaceutical Compositions for Controlled Release
Opioid Polymer Release System
Controlled Release Pharmaceutical Compositions for Prolonged Effect
Morphine Controlled Release System
Controlled Release Formulations with Continuous Efficacy
Application:
14/560,579 →
Publication:
US 2015/0150812
Device for Intranasal Administration
Application:
14/590,824 →
Publication:
US 2015/0314084
Immediate Release Composition Resistant to Abuse by Intake of Alcohol
Pharmaceutical Compositions Resistant to Abuse
Unit Dose Formulations of Ketorolac for Intranasal Administration
Application:
14/947,319 →
Publication:
US 2016/0136089
Morphine Controlled Release System
Pharmaceutical Tablet
Patent:
640,366 →
Application:
29/367,466 →
Related Assignments
(17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 19, 2009
From: DOWNIE, KEN; PEDERSEN, ANDERS VAGNO; HAAHR, ANNE-METTE; HEMMINGSEN, PERNILLE HOYRUP
To: EGALET A/S
Reel/Frame 023547/0410 →
Assignment of Assignor's Interest
May 4, 2012
From: ANDERSEN, CHRISTINE; FISCHER, GINA; BAR-SHALOM, DANIEL; SLOT, LILLIAN
To: EGALET A/S
Reel/Frame 028160/0735 →
Assignment of Assignor's Interest
Oct 1, 2015
From: LUITPOLD PHARMACEUTICALS, INC.
To: EGALET US, INC.
Reel/Frame 036702/0474 →
Security Interest
Aug 31, 2016
From: EGALET CORPORATION; EGALET US, INC.; EGALET LTD
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 039600/0791 →
Corrective Assignment to Correct the Omitted Inventor Previously Recorded at Reel: 019693 Frame: 0031. Assignor(S) Hereby Confirms the Assignment.
Sep 16, 2016
From: BAR-SHALOM, DANIEL; SLOT, LILLIAN; FISCHER, GINA; HEMMINGSEN, PERNILLE HOYRUP
To: EGALET A/S
Reel/Frame 040054/0790 →
Change of Address
Oct 3, 2016
From: EGALET LTD.
To: EGALET LTD.
Reel/Frame 040293/0249 →
Change of Address
Oct 3, 2016
From: EGALET US, INC.
To: EGALET US, INC.
Reel/Frame 040282/0873 →
Grant of Security Interest in Patents
Mar 20, 2019
From: EGALET CORPORATION; EGALET US, INC.; EGALET LIMITED
To: CANTOR FITZGERALD SECURITIES, AS COLLATERAL AGENT
Reel/Frame 050152/0828 →
Release of Security Interest
Apr 12, 2019
From: CANTOR FITZGERALD SECURITIES, AS AGENT AND AS COLLATERAL AGENT
To: EGALET CORPORATION; EGALET LIMITED; EGALET US, INC.
Reel/Frame 048869/0749 →
Assignment of Assignor's Interest
Jun 18, 2019
From: EGALET LTD
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 049505/0851 →
Change of Name
Jul 11, 2019
From: EGALET US INC.
To: ZYLA LIFE SCIENCES US INC.
Reel/Frame 049736/0775 →
Release of Security Interest
Sep 13, 2019
From: U.S. BANK NATIONAL ASSOCIATION
To: EGALET CORPORATION; EGALET US, INC.; EGALET LTD
Reel/Frame 050367/0019 →
Release of Security Interest in Patents
May 21, 2020
From: CANTOR FITZGERALD SECURITIES, AS AGENT AND AS COLLATERAL AGENT
To: ZYLA LIFE SCIENCES (F/K/A EGALET CORPORATION); ZYLA LIFE SCIENCES US INC. (F/K/A EGALET US, INC.); EGALET LIMITED
Reel/Frame 052740/0025 →
Security Interest
Sep 22, 2020
From: ADARE PHARMACEUTICALS, INC.; ADARE PHARMACEUTICALS USA, INC.
To: CRESCENT AGENCY SERVICES LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 053849/0967 →
Security Interest
Nov 8, 2022
From: ADARE PHARMACEUTICALS, INC.; ADARE PHARMACEUTICALS USA, INC.
To: TEAL MIDCO HOLDINGS, L.P.
Reel/Frame 061698/0541 →
Change of Name
Jan 19, 2023
From: ZYLA LIFE SCIENCES, INC.
To: ZYLA LIFE SCIENCES, LLC
Reel/Frame 062434/0955 →
Change of Name
Jan 19, 2023
From: ZYLA LIFE SCIENCES US INC.
To: ZYLA LIFE SCIENCES US, LLC
Reel/Frame 062434/0818 →